1-(cyclopropylmethyl)-6-(dimethylaminomethylidene)-7-oxo-4,5-dihydroindole-2-carboxylic acid
C16H20N2O3 — CID 172850721
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(cyclopropylmethyl)-6-(dimethylaminomethylidene)-7-oxo-4,5-dihydroindole-2-carboxylic acid
1-(cyclopropylmethyl)-6-(dimethylaminomethylidene)-7-oxo-4,5-dihydroindole-2-carboxylic acid (PubChem CID 172850721) has the molecular formula C16H20N2O3 and a molecular weight of 288.35 g/mol. Its IUPAC name is 1-(cyclopropylmethyl)-6-(dimethylaminomethylidene)-7-oxo-4,5-dihydroindole-2-carboxylic acid.
Molecular Properties
| Compound Name | 1-(cyclopropylmethyl)-6-(dimethylaminomethylidene)-7-oxo-4,5-dihydroindole-2-carboxylic acid |
|---|---|
| PubChem CID | 172850721 |
| Molecular Formula | C16H20N2O3 |
| Molecular Weight | 288.35 g/mol |
| Exact Mass | 288.15 |
| IUPAC Name | 1-(cyclopropylmethyl)-6-(dimethylaminomethylidene)-7-oxo-4,5-dihydroindole-2-carboxylic acid |
| SMILES | CN(C)C=C1CCc2cc(C(=O)O)n(CC3CC3)c2C1=O |
| InChI | InChI=1S/C16H20N2O3/c1-17(2)9-12-6-5-11-7-13(16(20)21)18(8-10-3-4-10)14(11)15(12)19/h7,9-10H,3-6,8H2,1-2H3,(H,20,21) |
| InChIKey | YAMFGFBNNDCMHC-UHFFFAOYSA-N |
| XLogP | 2.17 |
| TPSA | 62.54 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 288.35 |
| LogP ≤ 5 | 2.17 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172850721 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.